The experience of using cascade plasmofiltration in combined treatment with systemic lupus erythematosus on the background of programmed hemodialysis


Cite item

Full Text

Abstract

The results of combined treatment of systemic lupus erythematosus with the use of extracorporeal hemocorrection on the background of replacement therapy for kidney function are presented. The dynamics of the activity of the disease, assessed on the scales recommended by the European League against rheumatism, is presented. The analysis of humoral immunity indices and markers of inflammation before and after the application of efferent therapy methods is carried out. Thus, after applying the first operation cascade plasma filtration using fractionator plasma «Cascadeflo EC40», was a decrease in disease activity with a very high to a high degree, also decreased the activity of systemic lupus erythematosus with high to low degrees of activity after application of the second operation of systemic lupus erythematosus using plasma fractionator «Cascadeflo EC20». The results of combined treatment testify to the high effectiveness of therapeutic apheresis in the complex treatment of systemic lupus erythematosus. Operations cascade plasma filtration as part of combination immunosuppressive therapy allows to correct the main factors of the pathogenesis of systemic lupus erythematosus (antinuclear factor, antibodies to double-deoxyribonucleic acid, antibodies to histones, total immunoglobulins of classes G, M, A, circulating immune complexes, inflammation markers) selectively removing them from the vascular bed. Thus, the inclusion cascade plasmafiltration operation in the combined treatment of systemic lupus erythematosus, allows to quickly remove the main factors of the pathogenesis, which leads to a rapid decrease in the disease activity and reduces the dosages of cytostatic and glucocorticoid therapy.

About the authors

A S Manuilov

Военно-медицинская академия им. С.М. Кирова

Email: andre.manuilov@yandex.ru
Санкт-Петербург

S N Bardakov

Военно-медицинская академия им. С.М. Кирова

Санкт-Петербург

A V Apchel

Военно-медицинская академия им. С.М. Кирова

Санкт-Петербург

A N Belskih

Военно-медицинская академия им. С.М. Кирова

Санкт-Петербург

M V Zakharov

Военно-медицинская академия им. С.М. Кирова

Санкт-Петербург

V V Tishko

Военно-медицинская академия им. С.М. Кирова

Санкт-Петербург

A M Ivanov

Военно-медицинская академия им. С.М. Кирова

Санкт-Петербург

References

  1. Бардаков, С.Н. Лечение миастении с использованием методов экстракорпоральной гемокоррекции: дис.. канд. мед. наук / C.Н. Бардаков. - СПб.: ВМА, 2016. - C. 82.
  2. Бицадзе, В.О. Катастрофический антифосфолипидный синдром. Вопросы патогенеза / В.О. Бицадзе [и др.] // Акушерство, гинекология и репродукция. - 2015. - Т. 9, № 2. - С. 32-53.
  3. Калинин, Н.Н. Клиническое применение экстракорпоральных методов лечения / Н.Н. Калинин. - М.: Трекпор Технолоджи. - 2006. - C. 61.
  4. Костюченко, А.Л. Эфферентная терапия (в комплексном лечении внутренних болезней) / А.Л. Костюченко. - СПб.: Фолиант. - 2003. - С.141- 161.
  5. Соколов, А.А. Современные экстракорпоральные технологии: каскадная плазмофильтрация / А.А. Соколов. - СПб.: Инно- вационная медицина, - 2013. - С. 36-39.
  6. Bertsias, G. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics / G. Bertsias [et al.] // Ann. Rheum. Dis. - 2008. - Vol. 67, № 2. - P. 195-205.
  7. Gatto, M. Emerging and critical issues in the pathogenesis of lupus / M. Gatto [et al.] // Autoimmun. Rev. - 2013. - Vol. 12, № 4. - P. 523-536.
  8. Kronbichler, A. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review / A. Kronbichler [et al.] // Autoimmun. Rev. - 2016. - Vol. 15, № 1. - P. 38-49.
  9. Muñoz, L.E. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE / L.E. Muñoz [et al.] // Autoimmun. Rev. - 2010. - Vol. 10, № 1. - P. 38-42.
  10. Murphy, G. Effect of gender on clinical presentation in systemic lupus erythematosus / G. Murphy, D. Isenberg // Rheumatol. Oxf. Engl. - 2013. - Vol. 52, № 12. - P. 2108-2115. 118 2 (62) - 2018 ВЕСТНИК РОССИЙСКОЙ ВОЕННО-МЕДИЦИНСКОЙ АКАДЕМИИ Клинические исследования
  11. Podolska, M.J. Inflammatory etiopathogenesis of systemic lupus erythematosus: an update / M.J. Podolska [et al.] // Inflamm. Res. - 2015. - Vol. 8. - P. 161-171.
  12. Radic, M. Regulatory and pathogenetic mechanisms of autoantibodies in SLE / M. Radic [et al.] // Autoimmunity. - 2011. - Vol. 44, № 5. - P. 349-356.
  13. Pagnoux, С. Indications for plasma exchange in systemic lupus erythematosus in 2005 / C. Pagnoux [et al.] // Lupus 2005. - Vol. 14, № 1. - P. 871-877.

Copyright (c) 2018 Manuilov A.S., Bardakov S.N., Apchel A.V., Belskih A.N., Zakharov M.V., Tishko V.V., Ivanov A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies